Re-visiting the HLA dogma
Eur Respir J
.
2019 Aug 29;54(2):1901440.
doi: 10.1183/13993003.01440-2019.
Print 2019 Aug.
Authors
Antoine Roux
1
2
,
Stijn E Verleden
3
Affiliations
1
Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Dept, Foch Hospital, Suresnes, France a.roux@hopital-foch.org.
2
Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
3
Leuven Lung Transplant Group, Dept of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
PMID:
31467186
DOI:
10.1183/13993003.01440-2019
No abstract available
Publication types
Editorial
Comment
MeSH terms
HLA Antigens
Histocompatibility Antigens Class I
Humans
Lung Transplantation*
Polymorphism, Single Nucleotide*
Tissue Donors
Substances
HLA Antigens
Histocompatibility Antigens Class I